EUVIMEDEUVIMED entdecken
Open Access

Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma

Yuki Hirami, Midori Filiz Nishimura, Tomohiro Urata, Michiko Morimoto, Yukina Maekawa, Tadashi Yoshino, Yoshito Nishimura, Yasuharu Sato

Journal of Clinical and Experimental Hematopathology · 2022 · 63 (1) · 25-31

DOI: 10.3960/jslrt.22043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2022. Verfasst von Yuki Hirami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Okayama University Graduate School of Health Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Receptors, Interleukin-2, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Interleukin-2Lymphoma, Large B-Cell, DiffuseHumansTumor Microenvironment

Stichwörter der Autor:innen

B symptomsdiffuse large B-cell lymphomaintravascular large B-cell lymphomalactate dehydrogenasesoluble interleukin-2 receptor

Substanzen

Receptors, Interleukin-2

Autor:innen und Institutionen

  • Department of Nursing, Okayama University Graduate School of Health Sciences, Okayama, Japan.
  • Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
  • Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
  • Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

Zitieren

APA

Hirami, Y., Nishimura, M. F., Urata, T., Morimoto, M., Maekawa, Y., Yoshino, T., Nishimura, Y., & Sato, Y. (2022). Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology, 63(1), 25-31. https://doi.org/10.3960/jslrt.22043

Vancouver

Hirami Y, Nishimura MF, Urata T, Morimoto M, Maekawa Y, Yoshino T, et al. Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 2022;63(1):25-31. doi:10.3960/jslrt.22043

BibTeX
@article{Hirami2022,
  author = {Hirami, Yuki and Nishimura, Midori Filiz and Urata, Tomohiro and Morimoto, Michiko and Maekawa, Yukina and Yoshino, Tadashi and Nishimura, Yoshito and Sato, Yasuharu},
  title = {Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2022},
  volume = {63},
  number = {1},
  pages = {25--31},
  doi = {10.3960/jslrt.22043}
}
Kostenlos starten →